Results 131 to 140 of about 23,143 (200)

Optimising Asparaginase Use and Managing Hypersensitivity in Australasia—A Clinical Practice Guideline From the Australian and New Zealand Children's Haematology/Oncology Group

open access: yesJournal of Paediatrics and Child Health, Volume 62, Issue 10, Page 1913-1920, October 2026.
ABSTRACT Background Asparaginase is a critical component of modern multi‐agent chemotherapy regimens for paediatric acute lymphoblastic leukaemia and lymphoblastic lymphoma, with inadequate exposure leading to inferior patient outcomes. Objectives To develop a clinical practice guideline for the use of asparaginase products in the Australasian context.
Matthew J. O'Connor   +15 more
wiley   +1 more source

A Scoping Review of 5-HT<sub>3</sub> Antagonist Antiemetic Medication Safety in the Management of Nausea and Vomiting of Pregnancy. [PDF]

open access: yesPharmacoepidemiol Drug Saf
Morgan S   +6 more
europepmc   +1 more source

Corrigendum to "D-pinitol modulates the anti-emetic effects of aprepitant, domperidone, and ondansetron in chicks" [Pharmaceut. Sci. Adv. 3, (2025), 100073]. [PDF]

open access: yesPharm Sci Adv
Rahman E   +15 more
europepmc   +1 more source

Ondansetron exhibits potent antiviral activity against enterovirus 71 infection in vitro and in vivo. [PDF]

open access: yesVirus Res
Li Z   +15 more
europepmc   +1 more source

Ondansetron inhibits seizure activity with electroconvulsive therapy: A case report

open access: yes, 1999
Ondansetron inhibits seizure activity with electroconvulsive therapy: A case ...
Michael Berk (13060851)   +1 more
core  

Home - About - Disclaimer - Privacy